The invention describes a method of treating upper airway disease by administeringa composition of one or more proinflammatory cytokine inhibitors sufficientto inhibit inflammation in the upper airways. The proinflammatory cytokinesthat are inhibited include TNF, IL-1 and IL-8. A medication dispensing unit whichincludes a container and a delivery system is used to administer the composition.The delivery system further encompasses a one-way valve, a microcatheter, ora liquid-pressure type sprayer.